KYNB
KYNTRA BIO, INC.
NASDAQ · Healthcare · Medical - Pharmaceuticals · US
$7.08
−0.35%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 4.26x
Trailing multiples
Trailing twelve months
- P/E TTM
- 0.12x
- PEG TTM
- —
- Price / book
- -0.95x
- Price / sales
- 6.20x
- Price / cash flow
- -0.75x
Enterprise value
- Enterprise value
- -$40.7M
- EV / sales
- -8.81x
- EV / EBITDA
- 0.43x
- EV / EBIT
- 0.80x
- Market cap
- $28.6M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026